Topical Glucose Induces Claudin-1 and Filaggrin Expression in a Mouse Model of Atopic Dermatitis and in Keratinocyte Culture, Exerting Anti-inflammatory Effects by Repairing Skin Barrier Function
Atopic dermatitis (AD) is a chronic inflammatory skin disease. Corticosteroids, which are widely used for AD treatment, have adverse effects, and alternative treatments are urgently needed. This study examined the effect of topical application of high-dose glucose on inflamed skin in a murine model...
Saved in:
Main Authors: | Kiyoko Yamada (Author), Kenji Matsushita (Author), Jingshu Wang (Author), Takuro Kanekura (Author) |
---|---|
Format: | Book |
Published: |
Medical Journals Sweden,
2017-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Pathogenesis of Atopic Dermatitis: The Role of Filaggrin
by: Tamarachiara Kuntjoro, et al.
Published: (2017) -
Skin barrier in atopic dermatitis: beyond filaggrin
by: Mariana Colombini Zaniboni, et al.
Published: (2016) -
Filaggrin Defect at Atopic Dermatitis: Modern Treatment Options
by: Nikolay N. Murashkin, et al.
Published: (2022) -
Analysis of filaggrin 2 gene polymorphisms in patients with atopic dermatitis,
by: Amanda Hertz, et al.
Published: (2020) -
Feeding filaggrin: effects of L-histidine supplementation in atopic dermatitis
by: Tan SP, et al.
Published: (2017)